Trial of Sinovac's measles mumps and rubella virus vaccine in China
Latest Information Update: 25 Mar 2015
At a glance
- Drugs Measles mumps and rubella vaccine Sinovac Biotech (Primary)
- Indications Measles; Mumps; Rubella
- Focus Adverse reactions
Most Recent Events
- 25 Mar 2015 New trial record
- 17 Mar 2015 The clinical trial application for this study of measles mumps and rubella virus vaccine was filed with the China Food and Drug Administration in April 2011, and Sinovac obtained the clinical trial license in December 2014, according to a company media release.